Whole-body MRI in oncology: acquisition protocols, current guidelines, and beyond.
Fabio ZugniLeonardo MarianiDoenja M J LambregtsRoberta MaggioniPaul Eugene SummersVincenza GranataAnnarita PecchiGiuseppe Di CostanzoFederica De MuzioNicolò CardobiAndrea GiovagnoniGiuseppe PetraliaPublished in: La Radiologia medica (2024)
Acknowledging the increasing use of whole-body magnetic resonance imaging (WB-MRI) in the oncological setting, we conducted a narrative review focusing on practical aspects of the examination and providing a synthesis of various acquisition protocols described in the literature. Firstly, we addressed the topic of patient preparation, emphasizing methods to enhance examination acceptance. This included strategies for reducing anxiety and patient distress, improving staff-patient interactions, and increasing overall patient comfort. Secondly, we analysed WB-MRI acquisition protocols recommended in existing imaging guidelines, such as MET-RADS-P, MY-RADS, and ONCO-RADS, and provided an overview of acquisition protocols reported in the literature regarding other expanding applications of WB-MRI in oncology, in patients with breast cancer, ovarian cancer, melanoma, colorectal and lung cancer, lymphoma, and cancers of unknown primary. Finally, we suggested possible acquisition parameters for whole-body images across MR systems from three different vendors.
Keyphrases
- magnetic resonance imaging
- contrast enhanced
- case report
- diffusion weighted imaging
- systematic review
- magnetic resonance
- prostate cancer
- clinical practice
- mass spectrometry
- rectal cancer
- depressive symptoms
- diffuse large b cell lymphoma
- physical activity
- sleep quality
- tyrosine kinase
- radical prostatectomy
- molecularly imprinted
- young adults